®
Bella One PAP
®
The Bella One PAP is a FDA-approved test to screen for presence of human papillomavirus (HPV) DNA along with genotyping for high risk strains of HPV. The molecular panel also screens for presence of sexually transmitted infections and bacterial vaginosis pathogens that pose a threat to women's health
Bella One PAP Panel Menu
Performance: 100% sensitivity and 99.8% specificity
Sample Type: Cervical Vaginal
Methodology: Real-Time PCR
STI Molecular Assay Panel
BV Assay Molecular Panel
Chlamydia trachomatis
Trichomonas vaginalis
Neisseria gonorrhoeae
Mycoplasma genitalium
Mycoplasma hominis
Ureaplasma urealyticum
Ureaplasma parvum
Herpes simplex virus Type 1
Herpes simplex virus Type 2
Gardnerella vaginalis
Prevotella bivia
Atopobium vaginae
Mobiluncus curtisii
Bacteroides fragilis
Megasphaera Type 1
Pan–Lactobacillus
Bacterial vaginosis
Boost effectiveness of patient testing
Awareness about the link between HPV and cervical cancer has grown exponentially – leading to earlier detection and prevention. The CDC estimates that up to 93 percent of cervical cancers can be prevented. And yet, 33 percent of the 12,000 women who are diagnosed annually will die.
Why Bella One PAP?
The Bella One PAP screens for presence of Human Papilloma Virus (HPV) DNA as well as precancerous cells to determine whether a woman is at high-risk for developing cervical precancerous or cancerous conditions. – in addition Bella One Pap is design to test for a host of other infectious gynecological conditions.
Ultra Solutions
Molecular Reporting
No more, complicated, redundant paperwork or late reports. As a
service oriented, independent and fully certified provider, PCG
Molecular can streamline the process and put the focus where it
belongs– on you, the client. Our policy of speedy and efficient
turnaround for our clients means fast access to the information you
need via all forms of electronic transmittal and increased efficiency
in the day to day operations of your own practice.